Fidelity Investments’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782M | Sell |
|
|||||
|
2025
Q1 | $728M | Sell |
|
|||||
|
2024
Q4 | $651M | Sell |
|
|||||
|
2024
Q3 | $733M | Sell |
|
|||||
|
2024
Q2 | $671M | Sell |
|
|||||
|
2024
Q1 | $747M | Sell |
|
|||||
|
2023
Q4 | $644M | Sell |
|
|||||
|
2023
Q3 | $481M | Sell |
|
|||||
|
2023
Q2 | $459M | Sell |
|
|||||
|
2023
Q1 | $552M | Sell |
|
|||||
|
2022
Q4 | $639M | Sell |
|
|||||
|
2022
Q3 | $545M | Sell |
|
|||||
|
2022
Q2 | $492M | Sell |
|
|||||
|
2022
Q1 | $628M | Sell |
|
|||||
|
2021
Q4 | $721M | Sell |
|
|||||
|
2021
Q3 | $859M | Buy |
|
|||||
|
2021
Q2 | $708M | Buy |
|
|||||
|
2021
Q1 | $693M | Buy |
|
|||||
|
2020
Q4 | $891M | Buy |
|
|||||
|
2020
Q3 | $816M | Buy |
|
|||||
|
2020
Q2 | $710M | Buy |
|
|||||
|
2020
Q1 | $538M | Buy |
|
|||||
|
2019
Q4 | $664M | Buy |
|
|||||
|
2019
Q3 | $458M | Buy |
|
|||||
|
2019
Q2 | $540M | Sell |
|
|||||
|
2019
Q1 | $552M | Buy |
|
|||||
|
2018
Q4 | $263M | Buy |
|
|||||
|
2018
Q3 | $294M | Buy |
|
|||||
|
2018
Q2 | $222M | Sell |
|
|||||
|
2018
Q1 | $244M | Buy |
|
|||||
|
2017
Q4 | $145M | Hold |
|
|||||
|
2017
Q3 | $132M | Buy |
|
|||||
|
2017
Q2 | $89.9M | Hold |
|
|||||
|
2017
Q1 | $90.7M | Buy |
|
|||||
|
2016
Q4 | $63.8M | Buy |
|
|||||
|
2016
Q3 | $50.5M | Hold |
|
|||||
|
2016
Q2 | $33.3M | Buy |
|
|||||
|
2016
Q1 | $42.6M | Sell |
|
|||||
|
2015
Q4 | $42.3M | Buy |
|
|||||
|
2015
Q3 | $22.4M | Buy |
|
|||||
|
2015
Q2 | $18.4M | Buy |
|
|||||
|
2015
Q1 | $17M | Buy |
|